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ABSTRACT G-protein-coupled receptors (GPCRs) are involved in cell communication processes and with mediating such
senses as vision, smell, taste, and pain. They constitute a prominent superfamily of drug targets, but an atomic-level structure is
available for only one GPCR, bovine rhodopsin, making it difﬁcult to use structure-based methods to design receptor-speciﬁc
drugs. We have developed the MembStruk ﬁrst principles computational method for predicting the three-dimensional structure
of GPCRs. In this article we validate the MembStruk procedure by comparing its predictions with the high-resolution crystal
structure of bovine rhodopsin. The crystal structure of bovine rhodopsin has the second extracellular (EC-II) loop closed over
the transmembrane regions by making a disulﬁde linkage between Cys-110 and Cys-187, but we speculate that opening this
loop may play a role in the activation process of the receptor through the cysteine linkage with helix 3. Consequently we
predicted two structures for bovine rhodopsin from the primary sequence (with no input from the crystal structure)—one with the
EC-II loop closed as in the crystal structure, and the other with the EC-II loop open. The MembStruk-predicted structure of
bovine rhodopsin with the closed EC-II loop deviates from the crystal by 2.84 A˚ coordinate root mean-square (CRMS) in the
transmembrane region main-chain atoms. The predicted three-dimensional structures for other GPCRs can be validated only by
predicting binding sites and energies for various ligands. For such predictions we developed the HierDock ﬁrst principles
computational method. We validate HierDock by predicting the binding site of 11-cis-retinal in the crystal structure of bovine
rhodopsin. Scanning the whole protein without using any prior knowledge of the binding site, we ﬁnd that the best scoring
conformation in rhodopsin is 1.1 A˚ CRMS from the crystal structure for the ligand atoms. This predicted conformation has the
carbonyl O only 2.82 A˚ from the N of Lys-296. Making this Schiff base bond and minimizing leads to a ﬁnal conformation only
0.62 A˚ CRMS from the crystal structure. We also used HierDock to predict the binding site of 11-cis-retinal in the MembStruk-
predicted structure of bovine rhodopsin (closed loop). Scanning the whole protein structure leads to a structure in which the
carbonyl O is only 2.85 A˚ from the N of Lys-296. Making this Schiff base bond and minimizing leads to a ﬁnal conformation only
2.92 A˚ CRMS from the crystal structure. The good agreement of the ab initio-predicted protein structures and ligand binding site
with experiment validates the use of the MembStruk and HierDock ﬁrst principles’ methods. Since these methods are generic
and applicable to any GPCR, they should be useful in predicting the structures of other GPCRs and the binding site of ligands to
these proteins.
INTRODUCTION
Integral membrane proteins comprise 20–30% of genes
(Wallin and von Heijne, 1998) in humans and other forms of
life, playing an important role in processes as diverse as ion
translocation, electron transfer, and transduction of extra-
cellular signals. One of the most important classes of
transmembrane (TM) proteins is the G-protein-coupled
receptor (GPCR) superfamily which, upon activation by
extracellular signals, initiates an intracellular chemical
signal cascade to transduce, propagate, and amplify these
signals. GPCRs are involved in cell communication pro-
cesses and in mediating such senses as vision, smell, taste,
and pain. The extracellular signals inciting this transduction
are usually chemical, but for the opsin family, it is visible
light (electromagnetic radiation). Malfunctions in GPCRs
play a role in such diseases as ulcers, allergies, migraine,
anxiety, psychosis, nocturnal heartburn, hypertension,
asthma, prostatic hypertrophy, congestive heart failure,
Parkinson’s, schizophrenia, and glaucoma (Wilson and
Bergsma, 2000). Indeed, although they comprise ;3–4%
(Scho¨neberg et al., 2002) of the human genome, the GPCR
superfamily represents one of the most important families of
drug targets.
Within a class of GPCRs (for example, adrenergic
receptors) there are often several subtypes (for example,
nine for adrenergic receptors) all responding to the same
endogenous ligand (epinephrine and norepinephrine for
adrenergic receptors), but having very different functions in
various cells. In addition, many different types of GPCRs are
similar enough that they are affected by the antagonists or
agonists for other types (e.g., among adrenergic, dopamine,
serotonin, and histamine receptors), leading often to un-
desirable side effects. This makes it difﬁcult to develop
drugs to a particular subtype without side effects resulting
from cross-reactivity to other subtypes. To design such
subtype-speciﬁc drugs it is essential to use structure-based
methods, but this has not been possible because there is no
atomic-level structure available for any human GPCR.
Consequently design of subtype-speciﬁc drugs for GPCR
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targets is a very tedious empirical process, often leading
to drugs with undesirable side effects. The difﬁculty in
obtaining three-dimensional structures for GPCRs is obtain-
ing high-quality crystals of these membrane-bound proteins
sufﬁcient to obtain high-resolution x-ray diffraction data,
and the difﬁculty of using NMR to determine structure on
such membrane-bound systems. Hence we conclude that to
aid the structure-based drug design for GPCR targets, it is
essential to develop theoretical methods adequate to pre-
dict the three-dimensional structures of GPCRs from ﬁrst
principles. For globular proteins there have been signiﬁcant
advances in predicting the three-dimensional structures by
using sequence homologies to families of known structures
(Marti-Renom et al., 2000); however, this is not practical for
GPCRs, inasmuch as a high-resolution crystal structure is
available for only one GPCR, bovine rhodopsin—which has
low homology (\35%) to most GPCRs of pharmacological
interest.
Consequently we have been developing the MembStruk
method for ab initio or ﬁrst principles prediction of three-
dimensional structure for GPCRs from primary sequence
without using homology. MembStruk is based on the
organizing principle provided by knowing that a GPCR
has a single chain with seven helical TM domains threading
through the membrane—which we ﬁnd provides sufﬁcient
structural information (when combined with atomistic
simulations such as molecular dynamics and Monte Carlo)
for us to deduce three-dimensional structures for GPCRs that
are adequate for prediction of the binding site and relative
binding energy of agonists and antagonists. We have been
applying MembStruk to several GPCRs, where the valida-
tion has been based on the comparison of the predicted
binding site to experimental binding and mutation data. In
this article we describe the details of the MembStruk method
and validate the accuracy of the predictions by comparing
with the only high-resolution crystal structure available for
a GPCR, bovine rhodopsin.
Because the function of a GPCR is to signal to the
interior of the cell in the presence of a particular ligand
bound to the extracellular surface, it is most relevant to
determine the three-dimensional structure for the confor-
mation of the protein involved in activating G-protein. It is
widely thought that there are two distinct conformations of
GPCRs: one active and one inactive, in equilibrium, even
in the absence of ligands (Melia et al., 1997; Strange 1998;
Scho¨neberg et al., 2002). This equilibrium is shifted when
a ligand binds to the GPCR. Thus it would be valuable to
know four structures of the protein—the apo-protein in
both the active and inactive forms and the ligand-bound
form in both the active and inactive forms—so that one
could study the process of GPCR activation. Even for
bovine rhodopsin, there is crystal structure data for only
one of these four (the ligand-bound inactive form). We
postulate in this article a model of activation involving the
second extracellular (EC-II) loop and TM3 in which the
structure is assumed 1), to be in the active form when the
EC-II loop is open and 2), to be in the inactive form when
the EC-II loop is closed.
It is the closed conformation that is observed in the
rhodopsin crystal structure (Palczewski et al., 2000; Okada,
et al., 2001). In this article we report the MembStruk-
predicted structures for all four structures, although com-
parison can be made directly to experiment only for the
closed-loop-with-ligand case.
Except for bovine rhodopsin the only experimental vali-
dation for the accuracy of predicted GPCR structures must
rest on predicting the binding sites and energies for various
ligands and how they are modiﬁed by various mutations. To
make such predictions from ﬁrst principles, we developed
the HierDock method, which we validate here by predicting
the binding site of retinal in bovine rhodopsin both for the
experimental three-dimensional structure and for the pre-
dicted structures (open and closed loop).
The ﬁrst report on MembStruk and HierDock (Floriano
et al., 2000; Vaidehi et al., 2002) focused on olfactory
receptors, where ligand-binding data was available for 24
simple organic molecules to 14 different olfactory receptors
(Malnic et al., 1999). More recently these methods have been
applied to predict the structures and functions for GPCRs of
such diverse subfamilies as b1- and b2-adrenergic receptor,
dopamine D2 receptor, endothelial differentiation gene 6, and
sweet gustatory and olfactory receptors (Vaidehi et al., 2002 ;
Freddolino et al., 2004; Kalani et al., 2004; Floriano et al.,
2004a). The HierDock technique has also been validated for
globular proteins where the crystal structures are available
(Wang et al., 2002; Datta et al., 2002, 2003; Kekenes-Huskey
et al., 2003; Floriano et al., 2004b). We ﬁnd that the predicted
structures of the adrenergic and dopamine receptors lead
to binding sites for the endogenous ligands in excellent
agreement with the plentiful mutation and binding experi-
ments. Similarly, the predicted binding sites and afﬁnities for
endothelial differentiation gene 6, the mouse I7 and rat I7
olfactory receptors, and the human sweet receptor are con-
sistent with the available experimental binding data.
However, a quantitative assessment of the accuracy of
these structure and function prediction methods can be made
only for bovine rhodopsin, for which there is a high-re-
solution experimental crystal structure available with ligand
attached to the protein. Thus this article provides a detailed
study of rhodopsin to validate the various steps involved in
our procedures for prediction of the three-dimensional
structures of GPCRs (MembStruk) and for the prediction
of the binding site and the binding energy of the retinal
ligand to bovine rhodopsin (HierDock).
Computational Methods gives the details of the Mem-
bStruk and HierDock protocols, followed by Results and
Discussion, which describes the results of structure
and function prediction for bovine rhodopsin. These results
are also discussed in the Summary and in the Conclusions
section.
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COMPUTATIONAL METHODS
Force ﬁelds (FF)
All calculations for the protein used the DREIDING force ﬁeld (FF) (Mayo
et al., 1990) with charges from CHARMM22 (MacKerell et al., 1998) unless
speciﬁed otherwise. The nonbond interactions were calculated using the cell
multipole method (Ding et al., 1992) in MPSim (Lim et al., 1997).
The ligands were described with the DREIDING FF (Mayo et al., 1990)
using charges from quantum mechanics calculations on the isolated li-
gand; electrostatic potential charges calculated using Jaguar, Ver. 4.0
(Schrodinger, Portland, Oregon). For the lipids we used the DREIDING
FF with QEq charges (Rappe´ and Goddard, 1991). Some calculations were
done in the vacuum (e.g., ﬁnal optimization of receptor structure to approxi-
mate the low dielectric membrane environment). For structural optimization
in the solvent (water) we used the analytical volume Generalized-Born
(Zamanakos, 2002) approximation to Poisson-Boltzmann continuum
solvation.
We use the DREIDING FF due to its generic applicability to all molecules
constructed frommain group elements (particularly all organics), inasmuch as
wewill use ourmethods to predict the binding site and energy for a diverse set
of ligands of interest to pharmacology. Indeed, we ﬁnd below that the
minimized structure for bovine rhodopsin deviates from the crystal structure
by only 0.29 A˚ coordinate root mean-square error. The DREIDING FF with
CHARMM22charges has been validated formolecular dynamics simulations
and binding energy calculations for many proteins (Brameld and Goddard,
1999; Datta et al., 2003, 2002; Wang et al., 2002; Kekenes-Huskey et al.,
2003; Floriano et al., 2004b) with similar accuracy.
Validation of the force ﬁelds
The crystal structure of bovine rhodopsin (resolution, 2.80 A˚) was
downloaded from the protein structure database (PDB entry 1F88). The Hg
ions, sugars, andwaterswere deleted from this structure. This crystal structure
is missing 10 complete residues in loop regions and the side-chain atoms for
15 additional residues. We added the missing residues and side chains using
WHATIF (Vriend, 1990). Then we added hydrogens to all the residues using
the PolyGraf software. We then ﬁxed the TM helices and minimized (using
conjugate gradients) the structure of the loop region to a root mean-square
force of 0.1 kcal/mol per A˚. The potential energy of the entire structure of
rhodopsin was then minimized (using conjugate gradients) to a root mean-
square force of 0.1 kcal/mol per A˚ . This minimized structure deviates from
the x-ray crystal structure by 0.29 A˚ coordinate root mean-square (CRMS)
error over all atoms in the crystal structure. This is within the resolution of the
crystal structure, validating the accuracy of the FF and the charges. This FF-
minimized crystal structure is denoted as Ret(x)/closed(xray).
The MembStruk protocol for predicting
structure of GPCRs
MembStruk uses the hydrophobic proﬁle of multisequence alignment of
GPCRs to assign the helical TM regions. This is combined with a series of
steps of a Monte Carlo-like systematic search algorithm to optimize the
rotation and translational orientation of the TM helices. This search
algorithm allows the structure to get over barriers and make the con-
formational search more comprehensive. This is followed by molecular dy-
namics (MD) calculations at a variety of coarse-grain to ﬁne-grain levels in
explicit lipid bilayer.
MembStruk was ﬁrst described in Floriano et al. (2000). This method
(now labeled as MembStruk1.0), was improved to include energy
optimization to determine the rotation of helices in the seven-helical TM
bundle in Vaidehi et al. (2002) (now referred to as MembStruk2.0). In this
article we have modiﬁed MembStruk (now denoted as MembStruk3.5) to
also include optimization of the helix translations along their axes and
rotational optimization using hydrophobic moment of the helices. The
MembStruk3.5 procedure for predicting structures of GPCRs consists of the
following steps:
1. Prediction of TM regions from analysis of the primary sequence.
2. Assembly and coarse-grain optimization of the seven-helix TM bundle.
3. Optimization of individual helices.
4. Rigid-body dynamics of the helical bundle in a lipid bilayer.
5. Addition of interhelical loops and optimization of the full structure.
Henceforth in this article any reference to MembStruk always indicates
MembStruk3.5 unless speciﬁcally referenced otherwise.Wewill next discuss
some of the details of these steps in MembStruk. We should emphasize here
that these steps are all automated into a single MembStruk procedure. Thus
the sequence is fed to MembStruk and the result at the end is a ﬁnal three-
dimensional structure for the protein in the lipid bilayer. Of course we also
examine the various intermediate results generated in this procedure to allow
us to detect problems, to gain insight into the validity of the various criteria,
and to provide hints on improvements to make in the methods.
Step 1: Prediction of TM regions (TM2ndS)
Prediction of the TM helical regions for GPCRs from the sequence rests on
the assumption that the outer regions of the TM helices (in contact with the
hydrophobic tails of the lipids) should be hydrophobic, and that this
character should be largest near the center of the membrane (Donnelly,
1993; Eisenberg et al., 1984). The TM2ndS method uses this concept to
generate a hydrophobic proﬁle.
Step 1a: Sequence alignment
The ﬁrst part of Step 1 for TM2ndS uses the SeqHyd hydrophobic proﬁle
algorithm, which is based on peak signal analysis of the hydrophobic proﬁle.
We ﬁrst tested the use of the Prift hydrophobicity scale (Cornette et al.,
1987), but we found that the hydrophobicity index value for Arg was
opposite that expected for a charged residue, leading to obviously incorrect
assignments. We then switched to the use of the Eisenberg hydrophobicity
scale (Eisenberg et al., 1982), which is based on sound thermodynamic
arguments. This scale has a range from1.76 to 0.73 and works well for Arg
and other residues to give consistent TM predictions for the many systems
we have investigated. The Eisenberg scale has been used in all published
MembStruk results (1.0 onward). SeqHyd requires a multiple sequence
alignment using sequences related to bovine rhodopsin. This is constructed
by using an NCBI Blast search (Altschul et al., 1990, 1997) on bovine
rhodopsin (primary accession number P02699) to obtain protein sequences
with bit scores [200 but not identical (to avoid numerical bias in later
calculations) to bovine rhodopsin (E-value\e100). We prefer an ensemble
of sequences providing a uniform distribution of sequence identities from 35
to\100%. For bovine rhodopsin, this leads to the 43 sequences in Table S1
of the Supplemental Material. These 43 sequences plus bovine rhodopsin
were used in ClustalW (Thompson et al., 1994) to generate a pairwise
multiple sequence alignment. This sequence alignment included sequences
with identities to the bovine rhodopsin sequence as low as 40%. In general
we might include sequences with higher nonzero E-values, but including too
low a homology might lead to additional alignment problems.
Step 1b: Average consensus hydrophobicity and
initial TM assignment
The second part of Step 1 of TM2ndS is to calculate the consensus
hydrophobicity for every residue position in the alignment. This consensus
hydrophobicity is the average hydrophobicity (using the Eisenberg
hydrophobicity scale) of all the amino acids in that position over all the
sequences in the multiple sequence alignment. Then, we calculate the
average hydrophobicity over a window size (WS) of residues around every
residue position, using WS ranging from 12 to 20. This average value of
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hydrophobicity at each sequence position is plotted to yield the hydrophobic
proﬁle, as shown in Fig. 1 for WS ¼ 14. The baseline for this proﬁle serves
as the threshold value for determining the TM regions and is calculated as
follows.
First, we obtain the global average hydrophobicity value over all residues
in the protein but excluding the amino terminus region (34 residues) and the
carboxyl terminus region (42 residues). This global average is 0.041 for
bovine rhodopsin. If the baseline thus obtained does not resolve the expected
seven peaks, then TM2ndS automatically changes the baselines over a range
of 0.05 from the global average (thus0.009 to 0.091 for bovine rhodopsin).
The baseline closest to the average that yields the seven peaks is used for TM
region prediction. This modiﬁed baseline (base_mod) is shown as the pink
line in Fig. 1. It provides the basis for the accurate determination of the TM
regions in the sequence. This ﬁnal baseline may be interpreted physically as
a DG ¼ 0 value above which residues are thermodynamically stable in the
transmembrane and below which they are not. This baseline is unique to
the particular protein to which it is being applied, with its individual
environmental factors (water clusters, ions, hydrophobic or hydrophilic
ligand or interhelical interactions, membrane composition) that may change
the relative stability of any particular residue.
Below WS ¼ 12 the ﬂuctuations in hydrophobicity (noise) are too large
to be useful. The lowest WS that yields seven peaks (with peak length[10
and 0.8) is denoted as WSmin. The peaks ranges for WSmin are used as input
for the helix-capping module discussed in the next section.
Fig. 1 shows that assigning the TM region to helix 7 is a problem
because it has a shorter length and a lower intensity peak hydrophobicity
compared with all the other helices. This has been observed for other
GPCRs (Vaidehi et al., 2002). The low intensity of helix 7 arises because
it has fewer highly hydrophobic residues (Ile, Phe, Val, and Leu) and
because it has a consecutive stretch of hydrophilic residues (e.g.,
KTSAVYN). These short stretches of hydrophilic residues (including Lys-
296) are involved in the recognition of the aldehyde group of 11-cis-retinal
in rhodopsin. For such cases, we use the local average of the hydro-
phobicity (from minimum to minimum around this peak) as the baseline
for assigning the TM predictions. TM2ndS automatically applies this
additional criteria when the peak length is\23, the peak area is\0.8, and
the local average >0.5 less than the base_mod. For bovine rhodopsin only
TM7 satisﬁes this criterion and the local average (0.011) is shown by the
red line in Fig. 1. Thus, this local average is automatically applied for
proteins where the residues are relatively hydrophilic but in which the
helix might still be stable because of local environmental factors
(mentioned above) that stabilize these residues.
Step 1c: Helix capping in TM2ndS
It is possible that the actual length of the helix would extend past the
membrane surface. Thus, we carry out a step aimed at capping each helix at
the top and bottom of the TM domain. This capping step is based on
properties of known helix breaker residues, but we restrict the procedure so
as not to extend the predicted TM helical region more than six residues. We
consider the potential helix breakers (Donnelly et al., 1994) as P and G;
positively charged residues as R, H, and K; and negatively charged residues
as E and D.
TM2ndS ﬁrst searches up to four residues from the edge going inwards
from the initial TM prediction obtained from the previous section for a helix
breaker. If it ﬁnds one, then the TM helix edges are kept at the initial values.
However, if no helix breaker is found, then the TM helical region is extended
until a breaker is found, but with the restriction that the helix not be extended
more than six residues on either side. The shortest helical assignment
allowed is 21, corresponding to the shortest known helical TM region. This
lower size limit prevents incorporation of narrow noise peaks into TM
helical predictions.
We have used this TM2ndS algorithm for predicting the structure for
;10 very different GPCR classes (Vaidehi et al., 2002). In each case the
predicted binding site and binding energy agrees well with available
experimental data, providing some validation of the TM helical region
prediction. However, only for bovine rhodopsin can we make precise
comparisons to an experimental structure. Fig. 2 compares the predictions of
TM helical regions for bovine rhodopsin to the TM helical regions as
assigned in the crystal structure (Palczewski et al., 2000). To determine
which residues have an a-helical conformation, we analyzed the fc
angles using PROCHECK (Laskowski et al., 1993) and considered the
experimental structure to be in an a-helix if 37\ f\77 and 27\
c \ 67. This led to slightly shorter helices than quoted in the crystal
structure article. Thus the lowercase letters in Fig. 2 indicate residues which
FIGURE 1 Hydrophobicity proﬁle from TM2ndS for bovine rhodopsin at
window size of WS¼ 14. The pink line (at 0.07) is the base_mod (described
in Step 1, average consensus hydrophobicity and initial TM assignment)
used as the baseline in identifying hydrophobic regions. The predicted TM
domains are indicated by the orange lines (after capping). The blue lines
show the predictions before helix capping. Each tick mark indicates the
sequence number for the alignment based on bovine rhodopsin (100 residues
per panel). The residues at every ﬁfth position are indicated below each
panel. The partition of helix 7 into two parts results from the hydrophilic
residues near its center.
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are outside the above range but quoted as helices in the experimental article.
The results are as follows.
For TM1 our prediction adds P at the start and H at the end. In our ﬁnal
structure the (u, c) for this P is (not-applicable [N-terminus],43.6) and for
this H is (54.3,32.4), whereas the values obtained in the crystal structure
are (44.3, 24.9) and (72.5, 69.5), respectively. Since P and possibly
H might be expected to break the helix, we are considering modifying our
procedure to exclude such terminal P or H in the helix.
For TM2 our prediction adds HG at the end. In our ﬁnal structure the
(u, c) for this H and G are (73.6, 80.9) and (55.0, 148.8), whereas the
values obtained in the crystal structure are (74.2, 0.5) and (66.1, 9.0),
respectively. The crystal structure article considered the H as part of the
helix. Since HG could be expected to break the helix, we are considering
modifying our procedure to exclude the terminal HG in the helix. In fact, the
HG angles in our ﬁnal structure fall outside our criteria for a-helicity as
a result of the MembStruk optimization of the structure.
For TM3 our predictions miss the RYVVV assigned in the crystal structure
to the helix. Since the ﬁrst and second V do not have (u, c) in the usual range
for a-helices, we consider that the VVV should be excluded. However, the
polar character of RY leads TM2ndS to miss assigning them as part of the
helix. The crystallographic (u, c) values for R and Y residues are (55.5,
63.8) and (44.6, 56.3), whereas the values obtained in our ﬁnal
structure are (76.7, 51.4) and (62.9, 119.2). It should be pointed out that
the B-factors on the cytoplasmic end of the rhodopsin crystal structure are
high in this region of the helix (PDB entry 1F88). This indicates that the
helix is probably ﬂuxional even when the receptor is not activated.
Consequently caution should be used when comparing our predictions with
the crystal structure at this end. Also, because the helices are translated to
align hydrophobic centers in a later step of the procedure, this uncertainty in
TM helical prediction may only lead to local errors in atomic structure.
For TM4 our prediction adds G at the end and misses N at the start. The
crystallographic (u, c) for these N and G residues are (43.5, 59.6) and
(169.8, 5.4), whereas the values obtained in our ﬁnal structure are (93.9,
119.6) and (112.5, 118.4). Thus the predictions are ﬁne even though the
G and N were misassigned. We are considering modifying our procedure
to exclude a terminal G.
Compared to the crystal structure assignment, our prediction for TM5
adds LVF at the end and misses N at the start. In addition the GQ at the end
terminus in the crystal structure assignment have (u, c) outside the range for
a-helices. Thus we consider that the terminal GQLVF in the TM2ndS
predictions are in error, the largest error of any of the predictions. The
crystallographic (u, c) for these N and LVF residues are (69.3, 51.1),
(48.2, 36.7), (39.6, 27.1), and (58.0, 26.5), whereas the values
obtained in our ﬁnal structure are (109.9, 162.4), (55.1, 47.8),
(63.4,59.0), and (81.5, 59.3). The rhodopsin crystal structure has high
B-factors for the intracellular end of TM5 (just as for helix 3), suggesting
caution in making comparisons.
For TM6 our prediction addsH at the end and misses EVT at the start. The
crystallographic (u, c) values for these EVT and H residues are (57.6,
53.0), (54.1, 55.7), (56.3, 52.3), and (81.3, 48.8), whereas the
values obtained in our ﬁnal structure are (74.4, 72.3), (73.1, 130.8),
(16.9, 53.0), and (7.1, 87.7). Thus the predictions are ﬁne despite the
misassignments. We are considering modifying our procedure to exclude
a terminal H. In fact, the H angles in our ﬁnal structure fall outside our
criteria for a-helicity as a result of the MembStruk optimization of the
structure.
For TM7 our prediction adds P at the start and misses Y at the end. The
crystallographic (u, c) for the P and Y residues are (30.2, 48.1) and
(46.0, 55.0), whereas the value for P obtained in our ﬁnal structure is
(43.6, 23.2). Since the current MembStruk protocol does not model the
structures of the C- and N-termini, we did include the Y in our structure.
Thus the predictions are ﬁne despite the misassignments. We are considering
modifying our procedure to exclude a terminal P, but it is not obvious that
a modiﬁed method would automatically include the Y. In fact, the P angles in
our ﬁnal structure fall outside our criteria for a-helicity as a result of the
MembStruk optimization of the structure.
Overall, we consider that the predictions agree sufﬁciently well with the
crystal structure to be useful in building them into the assembly. In addition,
we can see several improvements in the capping procedure of TM2ndS that
could have decreased the errors in predicting which residues near the ends
are considered to be helix breakers for capping the TM helices. However,
this article is meant to validate the procedure we have been applying to many
systems and we did not want to change the procedure on the basis of our only
independent validation.
Step 2: Assembly and optimization of the seven-helical
TM bundle
Having predicted the seven TM helix domains using TM2ndS, we next build
them into the seven-helical TM bundle. This involves two steps: 1),
assembly and optimization of the relative translation and 2), rotation of the
helices.
Step 2a: Assembly of the seven TM helices into a bundle
Canonical right-handed a-helices are built for each helix using extended
side-chain conformations. Then the helical axes are oriented in space
according to the 7.5 A˚ electron density map of frog rhodopsin (Schertler,
1998). This 7.5 A˚ electron density map gives only the rough relative
orientations of the helical axes, with no data on atomic positions. This serves
as the starting point for optimization of the helices in the helical bundle. It
should be emphasized here that no information as to helical translations or
rotations was used. Since this electron density map showed no retinal
present, it is not clear whether this form of rhodopsin is active or inactive.
This same information has been used to build structures of;10 other GPCR
classes (Vaidehi et al., 2002). In each case the predictions of binding site and
binding energy agrees well with available experimental data, providing
some validation for this general approach of constructing the TM bundle of
GPCRs. However, for bovine rhodopsin we can make much more precise
comparisons to the experimental structures, as reported below.
FIGURE 2 The transmembrane helical predictions (labeled as after
capping) from TM2ndS compared with helix ranges from the bovine
rhodopsin x-ray crystal structure. The predictions before TM2ndS capping
are also shown. Those residues in the crystal structure that fall outside the
range of a-helicity (using analysis described in Step 1c, Helix Capping in
TM2ndS) are indicated in lowercase letters.
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Step 2b: Optimization of the relative translation of the
helices in the bundle
The translational and rotational orientation of each helix in the TM bundle is
critical to the nature and conformation of the binding site in the GPCR. We
do not use homology methods to predict these quantities because many
GPCRs have very remote sequence homology to rhodopsin (ranging down
to 10%) making it quite risky to base a three-dimensional structure on
homology modeling using the rhodopsin crystal structure as template. Also
we do not use atomistic molecular dynamics and molecular mechanics
methods to optimize the structure, because the large barriers between various
favorable positions can trap the conformation in local minima making such
approaches ineffective in repositioning the helices. Instead, we developed
methods to optimize the initial packing by translating and rotating the helices
over a grid of positions and by using various properties of the amino acids
in the sequence to suggest initial starting points. This Monte Carlo-like
systematic conformational search algorithm for rotational and translational
orientation of the helices allows the system to surmount barriers in the
conformational space.
Our general principle in repositioning the helices is that the outer surface
of the TM bundle (at least the middle regions) should be hydrophobic to
have stabilizing interactions with the hydrophobic chains of the lipid. We
imagine a midpoint plane through the lipid bilayer corresponding to the
contact of the hydrophobic chains, which we denote as the lipid midpoint
plane (LMP). We then assume that the hydrophobic regions of the TM
bundle will position themselves such that the middle of their maximum
hydrophobicity lies in this plane. We tested this concept for the crystal
structure of bovine rhodopsin as follows. We determined the hydrophobic
center (HC) for each helix as the maximum of the peak of hydrophobicity
from the proﬁles generated with various window sizes (since we go an
integer number of residues in each direction, window size is always even).
Our criterion for the best-ﬁt to experiment is that these seven positions when
applied to the crystal structure would all lie in a single plane that could be
taken as the LMP.
As shown in Fig. 3, the deviation of the calculated hydrophobic centers
from lying in a single plane in the rhodopsin crystal structure is a minimum
for WS 20 and 22. Thus Get_Centers calculates the overall hydrophobic
center of each TM helix based on the average of centers obtained for a range
of window sizes near 20. Get_Centers determines this range of window sizes
as follows. First, each hydrophobic center (HC) is calculated for WS ¼ 20.
Then, the HCs are calculated for WS 12–30 (excluding WS ¼ 20). For each
helix Get_Centers determines the window sizes that yield HC less than ﬁve
residues from the HC calculated at WS ¼ 20. For example, consider helix 1
in Table 1. Here HC ¼ 18 for WS ¼ 20. For windows sizes 12, 14, 16, 18,
22, 24, 26, 28, and 30 we ﬁnd HC ¼ 15, 13, 20, 18, 17, 18, 15, 16, and 13.
For WS 16, 18, 22, and 24 the HC are less than ﬁve from the value at WS ¼
20. Thus we consider that the hydrophobic center calculation is stable within
this regime of window sizes. The HC calculated for WS 16, 18, 22, and 24
for the helices 2–7 are also less than ﬁve residues from the centers at WS ¼
20. Thus, Get_Centers averages the HC for window sizes 16, 18, 22, and 24
and then it averages these values with the HC at WS¼ 20 for each TM helix.
Get_Centers takes these values (last column of Table 1) as the ﬁnal TM helix
centers. We ﬁnd that for bovine rhodopsin, these seven HCs deviate by a root
mean-square of 1.04 A˚ from a common plane.
Step 2c: Optimization of the rotational orientation
Once the helices are aligned along their helical axes according to the
calculated hydrophobic centers, the rotational orientation of the helices is
optimized using either or both of the following steps.
Orienting the net hydrophobic moment of each helix to point toward the
membrane (phobic orientation): In this procedure (denoted as CoarseR-
ot-H), the helical face with the maximum hydrophobic moment is
calculated for the middle section of each helix, denoted as the
hydrophobic midregion (HMR). The face is the sector angle obtained
as follows. 1), The central point of the sector angle is the intersection
point of the helical axis (the active helix that is being rotated) with the
common helical plane (LMP) and 2), the other two points forming the
arc, are the nearest projections (on the LMP) of the Ca vectors of the two
adjacent helices. The calculation of the hydrophobic moment vector is
restricted to this face angle. This allows the predicted hydrophobic
moment to be insensitive to cases in which the interior of the helix is
uncharacteristically hydrophilic (because of ligand or water interactions
within the bundle). Currently we choose HMR to be the middle 15
residues of each helix straddling the predicted hydrophobic center and
exhibiting large hydrophobicity. This hydrophobic moment is projected
onto the common helical plane (LMP) and oriented exactly opposite to
the direction toward the geometric center of the TM barrel (GCB). This
criterion is most appropriate for the six helices (excluding TM3) having
signiﬁcant contacts with the lipid membrane. The LMP is the plane that
most closely intersects the hydrophobic centers as described in Step 2b.
The GCB is calculated as the center of mass of the positions of the a-
carbons for each residue in the HMR for each helix summed over all
seven. This procedure is called phobic orientation.
Optimization of the rotational orientation using energy minimization
techniques (RotMin): In this procedure, each of the seven TMs is
optimized through a range of rotations and translations one at a time
(the active TM) while the other six helices are reoptimized in response.
After each rotation of the main chain (kept rigid) of each helix, the
side-chain positions of all residues for all seven helices in the TMR are
optimized (currently using SCWRL; Bower et al., 1997). The potential
FIGURE 3 The RMS deviation for various window sizes (WS) of the
central residues predicted from TM2ndS for bovine rhodopsin compared to
the best-ﬁt plane to the crystal structure minimized without ligand, Apo/
closed(xtal). This suggests that the best WS is 16–22.
TABLE 1
Window size
Helix number 12 14 16 18 20 22 24 26 28 30 HC
1 15 13 20 18 18 17 18 15 16 13 18.2
2 20 12 12 14 15 15 14 22 19 20 14.0
3 19 20 17 18 15 16 15 12 11 12 16.2
4 9 9 10 15 12 13 13 12 11 17 12.6
5 15 19 13 12 14 16 16 17 16 15 14.2
6 8 9 11 11 13 14 14 15 16 17 12.6
7 19 4 17 15 14 14 13 12 11 10 14.6
The last column shows the positions of the hydrophobic center (HC)
predicted for each TM by TM2ndS for various window sizes. The ﬁrst row
(in boldface) has the window sizes chosen to calculate this hydrophobic
center (underlined). Here position 1 corresponds to the ﬁrst residue in the
capped sequence in Fig. 2.
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energy of the active helix is then minimized (for up to 80 steps of
conjugate gradients minimization until an RMS force of 0.5 kcal/mol
per A˚ is achieved) in the ﬁeld of all other helices (whose atoms are
kept ﬁxed). This procedure is carried out for a grid of rotation angles
(typically every 58 for a range of 6508) for the active helix to
determine the optimum rotation for the active helix. Then we keep the
active helix ﬁxed in its optimum rotated conformation and allow each
of the other six helices to be rotated and optimized. Here the procedure
for each of the six helices one by one is 1), rotate the main chain; 2),
SCWRL the side chains; and 3), minimize the potential energy of all
atoms in the helix. The optimization of these six helices is done
iteratively until the entire grid of rotation angles is searched. This
method is most important for TM3, which is near the center of the
GPCR TM barrel and not particularly amphipathic (it has several
charged residues leading to a small hydrophobic moment). This
procedure is called RotMin.
For bovine rhodopsin, we used phobic orientation for placing the
hydrophobic moments away from the GCB for all seven helices.
Subsequently rotations were optimized using RotMin for helices 3 and 5
using small rotation angles of 62.58, 65.08, and 68.08. This optimizes the
only salt bridge in the TM region (between residues His-211 and Glu-122).
Coarse-grain rotation optimization combining both the energy optimization
and hydrophobic moments is expected to provide better optimized TM
helices than either one alone.
Step 3: Optimizing the individual helices
The optimization of the rotational and translational orientation of the helices
described in the above steps is performed initially on canonical helices (we
also apply them again to the helices after their optimizations described in
Step 3). To obtain a valid description of the backbone conformation for each
residue in the helix, including the opportunity of G, P, and charged residues
to cause a break in a helix, the helices built from the Step 2 were optimized
separately. In this procedure, we ﬁrst use SCWRL for side-chain placement,
then carry out molecular dynamics (MD) (either Cartesian or torsional MD
called NEIMO; Jain et al., 1993; Mathiowetz et al., 1994; Vaidehi et al.,
1996) simulations at 300 K for 500 ps, then choose the structure with the
lowest total potential energy in the last 250 ps and minimize it using
conjugate gradients.
This optimization step is important to correctly predict the bends and
distortions that occur in the helix due to helix breakers such as proline and
the two glycines. The MD also carries out an initial optimization of the side-
chain conformations, which is later further optimized within the bundle
using Monte Carlo side-chain replacement methods. This procedure allows
each helix to optimize in the ﬁeld due to the other helices in the optimized
TM bundle from Step 2.
Step 4: Addition of lipid bilayer and ﬁne-grain
reoptimization of the TM bundle
To the ﬁnal structure from Step 3 MembStruk adds two layers of explicit
lipid bilayers. This consists of 52 molecules of dilauroylphosphatidylcholine
lipid around the TM bundle of seven helices. This was done by inserting the
TM bundle into a layer of optimized bilayer molecules in which a hole was
built for the helix assembly and eliminating lipids with bad contacts (atoms
closer than 10 A˚). Then we used the quaternion-based rigid-body molecular
dynamics (RB-MD) in MPSim (Lim et al., 1997) to carry out RB-MD for 50
ps (or until the potential and kinetic energies of the system stabilized). In this
RB-MD step the helices and the lipid bilayer molecules were treated as rigid
bodies and we used 1-fs time steps at 300 K. This RB-MD step is important
to optimize the positions of the lipid molecules with respect to the TM
bundle and to optimize the vertical helical translations, relative helical
angles, and rotations of the individual helices in explicit lipid bilayers.
Step 5: loop building
Following the RB-MD, we added loops to the helices using the WHATIF
software (Vriend, 1990). After the addition of loops, we used SCWRL
(Bower et al., 1997) to add the side chains for all the residues. The loop
conformations were optimized by conjugate gradient minimization of the
loop conformations while keeping the TM helices ﬁxed. This step also
allows the general option of forming selected disulﬁde linkages (e.g.,
between the cysteines in the EC-II loop, which are conserved across many
GPCRs, and the N-terminal edge of TM3 or EC3). In the case of bovine
rhodopsin, the alignment of the 44 sequences from Step 1, Sequence
Alignment, indicates only one pair of fully conserved cysteines on the same
side of the membrane (extracellular side). The disulﬁde bond was formed
and optimized with equilibrium distances lowered in decrements of 2 A˚ until
the bond distance was itself 2 A˚. Then the loop was optimized with the
default equilibrium disulﬁde bond distance of 2.07 A˚. Annealing MD was
then used to optimize the EC-II loop at this stage. This involved 71 cycles,
in each of which the loop atoms were heated from 50 K to 600 K and back to
50 K over a period of 4.6 ps. During this process the rest of the atoms were
kept ﬁxed for the ﬁrst 330 ps and then the side chains within the cavity of the
protein in the vicinity of the EC-II loop were allowed to move for 100 ps to
allow accommodation of the loop. Subsequently a full-atom conjugate
gradient minimization of the protein was performed in vacuum using
MPSim (Lim et al., 1997). This leads to the ﬁnal MembStruk-predicted
structure for bovine rhodopsin.
The crystal structure for the retinal/rhodopsin complex has a well-deﬁned
b-sheet structure for EC-II, which we speculate to be involved as a mobile
gate for entry of 11-cis-retinal on the extracellular side of rhodopsin. Such
a gating mechanism is illustrated in Fig. 4, in which the helix 3 coupled to
this loop by a cysteine bond is the gatekeeper which responds to signaling
structural substates of rhodopsin as follows:
When rhodopsin binds 11-cis-retinal, the ground state conformation of
the receptor is stabilized, thus shifting helix 3 toward the intracellular
side (forming the D(E)RY-associated salt bridges at that end) and
closing the EC-II loop. In fact, 11-cis-retinal has been shown to be an
inverse agonist for G-protein signaling (Okada et al., 2001).
In response to absorption of a photon, the 11-cis-retinal isomerizes to the
all-trans conformation, inducing helix 3 to shift toward the
extracellular side. This induction of helix 3 movement may be direct
or indirect. It may be due to a direct clash of helix 3 with all-trans-
retinal. This is consistent with the result of a cross-linking experiment
in which the ionone ring of retinal interacts with Ala-269 when the
receptor is activated (Borhan et al., 2000). This may occur because the
trans-retinal clashes with helix 3 of the ground state rhodopsin crystal
structure (Bourne and Meng, 2000). The induction of helix 3
FIGURE 4 Schematic for a possible signaling mechanism in rhodopsin.
Note that the movement of helix 3 (caused by interaction with the trans-
isomer of retinal) exposes the DRY sequence to G-protein activation and as
a result closes the EC-II loop to maintain the ligand inside the bundle
sequence.
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movement may also occur indirectly in the following way: 11-cis-
retinal as observed in the crystal structure interacts with aromatic side
chains Trp-265 and Tyr-268 on helix 6. But all-trans-retinal does not
have this stabilizing interaction with helix 6, which should decrease
the energy barrier for helix 6 rotation (this has been observed in
preliminary MD calculation we carried out, and in reports in the
literature; Saam et al., 2002).
This motion (of helix 3 or helix 6) breaks the DRY-associated salt bridges
(Greasley et al., 2002) at the intracellular side. Helix 3 may have fewer
constraints to movement, but since it is coupled by a disulﬁde linkage
to the EC-II loop, movement on helix 3 would likely cause an opening
of the EC-II loop to allow Schiff base reversion and exit of the free all-
trans-retinal ligand. The breaking of this DRY salt bridge would also
allow hinge motion (Altenbach et al., 2001a,b) of helix 6 to expand the
molecular surface at the cytoplasmic end for G-protein binding. This
model is consistent with the experimental mutations studies in which
the disulﬁde has been shown to be important for ligand binding and
receptor activation (Scho¨neberg et al., 2002).
Building the loops without the constraint of coupling these cysteines leads
to an open EC-II loop very different from the crystal structure of bovine
rhodopsin. It is likely that both the open loop and closed loop structures play
an important role in GPCRs, and indeed general observations of GPCRs
suggests two distinct forms, one of which leads to activation of G-protein and
one of which does not. We consider that one of these is likely the closed form
and the other the open form. It seems likely that the ligandmight not be able to
diffuse into the active site when the loop is closed, and hence formost GPCRs
(other than bovine rhodopsin) we visualize the process of activation as 1), the
GPCRwith the open formofEC-II loop can bind selectively to the appropriate
ligand; 2), binding of the ligand favors closing of the EC-II loop; and 3), after
closure of the loop, G-protein activation may begin.
Thus we have built two structures for bovine rhodopsin (here,MS denotes
that the structure was predicted using MembStruk): Apo/closed(MS) has the
cysteine coupling observed in the crystal and is the structure we compare to
experiment after binding the retinal; and Apo/open(MS) is built without
a constraint, forming what we believe would be the conﬁguration which
binds initially to the ligand.
Function prediction for GPCRs
Since there are no experimental structures available for any human GPCR,
the only validation available for the accuracy of predicted structures for
human GPCRs is to predict the ligand binding sites and the ligand binding
energies. The accuracy in the predicted binding site can then be judged from
site-directed mutagenesis experiments on the residues predicted to control
selectivity. An even tougher test is to compare binding afﬁnity of ligands to
each other and to mutated proteins. For many GPCRs of pharmaceutical
interest there is ample experimental data on ligand binding constants as well
as agonist and antagonist inhibition constants for many GPCRs (for
a compilation of this literature, see http://www.gpcr.org).
To carry out such function validations for the predicted structures, it is
essential to have reliable and efﬁcient procedures for predicting binding site
and binding afﬁnities. Since the ligand binding site is completely unknown
for most GPCRs, we must scan the entire protein to identify likely binding
sites and conformation of each ligand, and then we must reliably rank the
relative binding energies of the various ligands in these sites. To do this we
employ the HierDock procedure, which has been tested and validated for
predicting ligand binding sites and ligand binding energies for many
globular and membrane-bound proteins (Vaidehi et al., 2002; Kekenes-
Huskey et al., 2003; Floriano et al., 2004b; Datta et al., 2003, 2002). These
studies show that the multistep hierarchical procedure in HierDock ranging
from coarse-grain docking to ﬁne-grain MD optimization leads to efﬁcient
and accurate predictions for ligand binding in proteins.
The HierDock method was ﬁrst described in Floriano et al. (2000), which
we label as HierDock1.0. The method was improved in Vaidehi et al. (2002),
which we label as HierDock2.0. In this article we present an improved
version that we label as HierDock2.5. The various steps involved in this
current procedure are as follows:
1. Sphere generation: We assume no knowledge of the ligand binding site
in GPCRs and hence the entire molecular surface of the receptor is
scanned to predict the energetically preferred ligand binding sites. The
negative of the molecular surface of the protein was used to deﬁne
potential binding regions within the receptor over which the various
ligand conformations are to be sampled. The void regions are mapped
FIGURE 5 The 13 regions shown as boxes used in scanning the entire
protein for the 11-cis-retinal putative binding site. The two boxes chosen as
binding sites by HierDock are shown in red. (A) Front view with N-terminus
at the bottom. (B) Top view obtained by rotating by 908 around the
horizontal axis in A so that the N-terminus is out of view. These two
orientations are used for all structures shown in this article.
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with spheres generated over the whole receptor using the Sphgen
program in DOCK 4.0. No assumptions were made on the nature or the
location of the binding site in these receptors. For bovine rhodopsin this
led to a total of 7474 spheres, which was partitioned into 13 overlapping
docking regions each with a volume of 10 A˚3 as shown in Fig. 5. We
excluded from docking regions in contact with the membrane or near the
intracellular region likely to be involved in binding to the G-protein. No
assumptions were made on the nature or the location of the binding site
in these regions.
2. Coarse-grain sampling: To locate the most favorable ligand binding
site(s), we used DOCK 4.0 (Ewing and Kuntz, 1997) to generate a set of
conformations for binding 11-cis-retinal (a ligand known to bind to
bovine rhodopsin) to each of the 13 regions. For this docking step we
used a bump ﬁlter of 10, a non-distance-dependent dielectric constant of
1.0, and a cutoff of 10 A˚ for energy evaluation. The ligands were docked
as nonﬂexible molecules to generate and score 100 conformations of the
ligand in each of the 13 regions. We then rejected any ligand
conformation with \90% of the surface area buried into the protein
and ranked the remainder by the ligand-protein interaction energy using
DREIDING FF. The best binding energy conformation among the 13
regions was chosen as the putative binding region. Other conformations
with binding energies within 100 kcal/mol of the best conformation were
also chosen as possible binding regions.
3. Construction of putative binding region using a more reﬁned sampling of
ligand-protein interactions: A set of overlapping boxes were used to
enclose the volume corresponding to the putative binding region (or
regions) determined in Step 2, which is now to be used for a new sampling
of ligand-protein conformations similar to Step 2.
4. Coarse-grain sampling of putative binding regions: To locate the most
favorable ligand binding site(s), we again used DOCK 4.0 to generate
a set of conformations for binding 11-cis-retinal (a ligand known to bind
to bovine rhodopsin) to the putative binding region. We again used
a bump ﬁlter of 10, a non-distance-dependent dielectric constant of 1.0,
and a cutoff of 10 A˚ for energy evaluation. The ligands were docked as
nonﬂexible molecules to generate and score 1000 conformations. We
selected the 10% (i.e., 100) with best DOCK 4.0 score for further
analysis.
5. Ligand-only minimization: The 100 best conformations selected from
Step 4 were conjugate-gradient-minimized, keeping the protein ﬁxed but
all atoms of the ligand movable. Minimized ligand conformations that
satisﬁed the buried surface area cutoff criterion of 75% were kept for the
next step.
6. Ligand-protein full minimization: The ligand/protein conformations
from Step 5 were further energy-minimized with all atoms (protein, lipid,
and ligand) movable using conjugate gradients. The structure with the
binding energy calculated by Eq. 1 was selected as
BE1 ¼ Energy½ligand in protein complex-
Energy½free ligand in solvent: (1)
Here the energy of the ligand in water is calculated using DREIDING FF
and analytical volume Generalized-Born continuum solvation method.
Since a substantial part of the complex is in contact with the membrane
environment, we did not solvate the complex.
7. Side-chain optimization: Using the best binding conformation from Step
6, the side-chain conformations for all the residues within 5 A˚ of the
bound 11-cis-retinal conformation were optimized using the SCREAM
side-chain optimization program (V. W. T. Kam, N. Vaidehi, and W. A.
Goddard 3rd, unpublished). The resulting ligand-protein structure was
ﬁnally optimized by conjugate gradient minimization allowing all atoms
to relax.
8. Iterative HierDock (optional): The protein from Step 7 (optimized with
ligand bound) was saved. Steps 4–6 were repeated again to obtain the
best possible conformation for the ligand within the protein (with side
chains optimized in the presence of the ligand). This step was performed
for bovine rhodopsin.
RESULTS AND DISCUSSION
We ﬁrst present the results for the validation of the HierDock
protocol on the crystal structure of bovine rhodopsin,
followed by results on structure and function prediction for
bovine rhodopsin. To clarify our notation we summarize it
here.
Ret(xtal)/closed(xtal) is obtained from the crystal structure
by minimizing using the DREIDING FF. It deviates from the
crystal structure by 0.29 A˚ CRMS. It has retinal bound as in
the crystal structure and has the closed form of the EC-II loop.
The retinal conformations differ by 0.22 A˚ CRMS. This
further validates the FF. Since they differ so little, the retinal in
the nonminimized crystal structure, Ret(xtal-noFF), is used as
the reference structure for the HierDock validation step.
Apo/closed(xtal) is obtained from Ret(xtal)/closed(xtal)
by removing the retinal and adding the proton to Lys-296. It
was minimized without ligand. It deviates from the crystal
structure by 0.74 A˚ CRMS. It is likely that this is a lower
bound on the change in structure upon removal of the retinal.
For a more complete optimization, we would use MD.
Ret(HD)/closed(xtal) is the predicted structure for 11-cis-
retinal obtained by applying HierDock to Apo/closed(xtal)
and then forming the Schiff base linkage to Lys-296 and
minimizing. The Ret(HD) deviates from Ret(xtal) by 0.62 A˚
CRMS. To distinguish the error in ligand conformation due
to the HierDock procedure from that due to MembStruk, the
structure Ret(HD)/closed(xtal) will serve as the reference
structure to compare to the predicted ligand conformations in
the MembStruk structures.
Apo/closed(MS) is the MembStruk-predicted structure
of the closed form, without the retinal. The TM bundle for
this structure deviates by 2.84 A˚ CRMS main-chain atoms
from Apo/closed(xtal) (4.04 A˚ CRMS for all TM atoms,
excluding H).
Ret(HD)/closed(MS) is the predicted structure for 11-cis-
retinal in the Apo/closed(MS) rhodopsin structure, obtained
by applying HierDock to Apo/closed(MS) and then form-
ing the Schiff base linkage to Lys-296 and minimizing the
energy. The Ret(HD) deviates from Ret(HD)/closed(xtal) by
2.92 A˚ CRMS.
Apo/open(MS) is the MembStruk-predicted structure of
bovine rhodopsin without the retinal. There are no experi-
ments with which to compare. This structure differs in the
TM region from Apo/closed(MS) by 0.11 A˚.
Ret(HD)/open(MS) is the predicted structure for 11-cis-
retinal in rhodopsin obtained by applying HierDock to Apo/
open(MS) and then forming the Schiff base linkage to Lys-
296 and minimizing. There are no experiments with which
to compare. The retinal differs from that in Ret(HD)/
closed(MS) by 1.74 A˚.
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Validation for function prediction HierDock
protocol for 11-cis-retinal on bovine rhodopsin
Bovine rhodopsin (a member of the opsin family) is the only
GPCR to be crystallized in its entirety at a high resolu-
tion (2.8 A˚). Thus we used this system as a test to validate
the HierDock protocol for predicting the binding sites of
GPCRs.
To test HierDock, we used the Apo/closed(xtal) structure
with the retinal removed and minimized. First we did
a complete HierDock scan as outlined above to predict the
binding of 11-cis-retinal to bovine rhodopsin. The crystal
structure of rhodopsin has the 11-cis-retinal covalently
bound to Lys-296 (between the aldehyde of 11-cis-retinal
and the N of the Lys), but for docking we cannot have
a covalent bond to the crystal. Thus we docked the full 11-
cis-retinal ligand (containing a full aldehyde group) and
considered the Lys-296 to be protonated.
We applied Steps 1–2 of the HierDock described above
for all 13 overlapping regions for Step 2 shown in Fig. 5. The
initial scan of the entire rhodopsin (Steps 1 and 2 in Function
Prediction for GPCRs) gave two good binding regions
shown as the red boxes in Fig. 5. The data for this scanning
step are shown in Table 2. The ﬁnal optimized best binding
structure for the retinal/rhodopsin complex from Step 6 of
HierDock deviates by 1.11 A˚ CRMS from the ligand in the
crystal structure as seen in Fig. 6, A and B. The binding site
(deﬁned as the seven residues that contribute at least 1 kcal/
mol to the bonding) of this ligand is shown in Fig. 9 B. Lys-
296 has hydrophilic interactions whereas the other side
chains have van der Waals interactions. This docked
structure has the retinal O 2.72 A˚ from the N of Lys-296.
In addition, the retinal O and the closest H of the protonated
Lys-296 N are just 2.35 A˚ apart, close enough to form an
H-bond (likely an intermediate step before Schiff base
formation). We then coupled these two units to form the
covalent CN bond to Lys-296 while eliminating the H2O.
After minimizing the full ligand-protein structure, we ﬁnd
that the predicted structure for 11-cis-retinal bonded to the
protein deviates from the crystal structure by only 0.62 A˚
CRMS as shown in Fig. 6, C and D. Most of this discrepancy
results because the FF-minimized structure of the retinal has
the ionone ring in a chair conformation which was retained in
our docking procedure, whereas the crystal structure has the
ionone ring in a half-chair conformation (which we calculate
to be 2 kcal/mol higher in energy than the chair conformation
within the minimized complex). This retinal/protein complex
minimized with the DREIDING FF, denoted Ret(HD)/
closed(xtal), serves as the reference structure for comparing
the predicted structures in later sections. We consider that
these results validate the HierDock protocol for a GPCR.
In addition, we used HierDock to determine the binding
site and best scoring ligand conformation for all-trans-
retinal, with the binding energy calculated using Eq. 1 above.
The binding energy for 11-cis-retinal was 1 kcal/mol
whereas that for all-trans-retinal was ;31 kcal/mol,
a difference of 32 kcal/mol. This compares well with the
experimental result that the retinal ligand/protein complex
stores 34.76 2.2 kcal/mol upon isomerization in the protein
(Okada et al., 2001). This stored energy might be used to
induce rigid-body helical motions needed for receptor
activation and G-protein binding. This excellent agreement
is probably fortuitous, inasmuch as we have not carried out
full optimizations of the all-trans conﬁguration, but it may be
partly because cis- and trans-retinal are neutral isomers of
each other with similar solvation energies.
Structure prediction of rhodopsin
using MembStruk
We used MembStruk3.5 as detailed in The MembStruk
Protocol for Predicting Structure of GPCRs to predict the
structure of bovine rhodopsin using only the protein
sequence. For the apo-rhodopsin we predicted two struc-
tures, one with the open EC-II loop and one with closed EC-
II loop. These represent two different states of rhodopsin
likely to play a role in activation of G-protein. The crystal
structure of rhodopsin has a closed EC-II loop with the
11-cis-retinal bound to it. To validate this predicted structure,
we should compare to the crystal structure for apo-rhodopsin
(without a bound 11-cis-retinal). However, this crystal
structure for the apo protein is not available. Thus instead
we will compare the predicted structure to the minimized
crystal structure of bovine rhodopsin after removing the 11-
cis-retinal. In making these comparisons, we predicted two
structures for apo-rhodopsin: 1), the open form, where no
restrictions were made on the structure of EC-II loop, i.e.,
Apo/open(MS); and 2), the closed form, where we assumed
that EC-II makes the same cysteine linkage as observed in
the crystal structure, i.e., Apo/closed(MS).
TABLE 2
Box Top 5% after coarse-grain ranking
1 2596, 2941, 2991, 3011, 4281
2 4440, 4621, 4625, 5509, 5513
3 2338, 2375, 2409, 2566, 2571
4 5844, 5961, 6006, 6244, 6278
5 None passed buried surface criteria
6 102, 118, 131, 136, 208
7 1366, 1370, 1374, 1374, 1379
8 No conformations generated from DOCK
9 12026
10 82, 139, 153, 377, 380
11 2348, 2348, 2566, 2843, 2843
12 No conformations generated from DOCK
13 551, 734, 931, 1110, 1226
Results from the coarse-grain docking step of HierDock to predict the
binding site(s) in Apo/closed(xray). The energies of the top 5% after
ranking (level 2 of HierDock) are shown for each box. Among all boxes,
the best coarse-grain score is underlined. The scores within 100 kcal/mol of
the top score are shown in bold.
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The predicted TM domains are compared to the rhodopsin
crystal structure in Fig. 2 and discussed in Step 1, Helix
Capping in TM2ndS.
After optimization of the helices using MD (300 K for 500
ps), most helices yield the same bends as in the crystal. Thus
helices 2 and 6 undergo signiﬁcant bending (due to Pro-267
in helix 6 and due to Gly-89 and Gly-90 in helix 2), which
is consistent with spin-labeling electron paramagnetic
resonance experiments (Farrens et al., 1996). In addition,
we ﬁnd that helix 7 bends near the two prolines, which has
also been shown by spin-labeling experiments (Altenbach
et al., 2001a,b). We ﬁnd that helix 1 undergoes signiﬁcant
bending due to a Gly/Pro combination, but this has not yet
been studied experimentally. Such bending at hinge sites
may be important for expanding the molecular surface
needed at the cytoplasmic side to allow G-protein binding.
We ﬁnd similar hinge-bending with MD when the trans-
isomer is bound to the helix assembly.
After assembling the optimized helices again into a bundle,
we carried out RotMin on helices 3 and 5, the only helix pair
with a potential salt bridge. The resulting seven-helix bundle
was then inserted into a lipid bilayer, and optimized using
rigid-body molecular dynamics as described in Step 4 of The
MembStruk Protocol for Predicting Structure of GPCRs.
This step leads to optimization of the vertical helical posi-
tions, relative helical angles, and rotations of the individual
helices within a lipid environment. The CRMS difference
before and after this rigid body MD is 1.10 A˚ for all atoms
and 0.98 A˚ for main-chain atoms. This is consistent with
the changes during this optimization step for other GPCRs
(Vaidehi et al., 2002).
After adding the intracellular and extracellular loops,
optimizing the side chains, and then optimizing the structure
in vacuum with the TM helical region ﬁxed (to eliminate bad
contacts in the loop region), we then optimized the entire
structure allowing all bonds and angles to change. These ab
initio predictions of the structure were carried out for both the
open and closed forms of the EC-II loop in apo-rhodopsin
leading to the Apo/open(MS) and Apo/closed(MS) struc-
tures, whereMS denotes a MembStruk-derived structure, and
FIGURE 6 (A–D) Validation of HierDock. (A) Front view of the 11-cis-retinal conformation determined by HierDock for Ret(HD)/closed(xray) (colored by
element ) compared to the published crystal structure (green). The CRMS difference in the ligand structures is 1.1 A˚. (B) Top view of A. This shows that
predicted position of the retinal aldehyde oxygen is 2.8 A˚ from the N of Lys-296, which is short enough for an H-bond. (C) Top view showing the result of
making the Schiff base bond of 11-cis-retinal to Lys-296 in A and minimizing the resulting structure (blue), compared with the crystallographic ligand structure
(red). The CRMS difference between these ligand structures is 0.62 A˚. (D) Top view of C.
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open or closed denotes the open or closed form of the EC-II
loop. Although the crystal structure has the 11-cis-retinal
bound, we will compare the predicted apo-rhodopsin struc-
tures to the minimized apo-protein of the crystal structure,
Apo/closed(xray).
Comparing Apo/closed(MS) to Apo/closed(xray) we ﬁnd
a CRMS difference of 2.85 A˚ in the main-chain atoms and
4.04 A˚ for all the atoms in the TM helical region. These
structures are compared graphically in Fig. 7 A. Comparing
all residues including loops (but ignoring the residues not
present or complete in the x-ray structure), the predicted
structure differs from the crystal structure by 6.80 A˚ in the
main chain and 7.80 A˚ CRMS for all atoms. The major
contribution to this CRMS is the low-resolution loop
region, which is likely to be quite ﬂuxional and may be
very different between crystal and solution. Speciﬁcally,
the predicted topology and fc angles of the EC-II loop
are consistent with that of a b-sheet. However, the speciﬁc
twist of this b-sheet in the x-ray structure was not
predicted well. Although this may be partly due to packing
effects in the crystal structure, we consider that our
prediction of the general topology of the EC-II loop to act
as a ‘‘plug’’ to restrict retinal binding is adequate but that
speciﬁc interactions with retinal may not be predicted well.
In the function prediction results discussed below in the
subsection called Apo/Closed(MS), we ﬁnd that there are
no speciﬁc favorable interactions between the ligand and
the EC-II loop before Schiff base bond formation in the
crystal structure (Fig. 9 B). Thus the EC-II may function
initially primarily as an unspeciﬁc ‘‘plug’’ to disfavor
certain ligand conformations. After Schiff base bond
formation, the ligand is then stabilized by Glu-181 in the
EC-II loop (Fig. 10 A). Thus accurate prediction of
the atomic structure of the EC-II loop remains an important
challenge.
We ﬁnd that Apo/open(MS) deviates from Apo/
closed(MS) by a CRMS difference of 0.11 A˚ in the main-
chain atoms and 0.68 A˚ for all the atoms in the TM helical
region. These structures are compared graphically in Fig. 7
C. This small difference in CRMS in the transmembrane
region suggests that we need to carry out long timescale
molecular dynamics for the helices to accommodate the EC-
II loop conformational change. Comparing all residues, the
predicted structure differs from the crystal structure by 4.74
A˚ in the main chain and 5.0 A˚ CRMS for all atoms. There
is no experimental structure Apo/open(xray) with which to
compare Apo/open(MS).
HierDock function prediction for
Apo_rhod (MS) structures
Except for bovine rhodopsin, essentially all applications of
HierDock to GPCRs must use predicted structures rather
than experimental structures. The question here is that, given
the errors in predicting the GPCR structure (2.8 A˚ CRMS in
the TM helical region), can we hope to get accurate
predictions in the binding site and binding energy? We will
now test how well HierDock determines the binding site of
11-cis-retinal to the predicted rhodopsin structures Apo/
open(MS) and Apo/closed(MS).
Here we repeated the full process described in Function
Prediction for GPCRs. The void space for both the Apo/
open(MS) and Apo/closed(MS) structures were partitioned
into fourteen 7 A˚ 3 7 A˚ 3 7 A˚ boxes and scanned for the
putative binding site of 11-cis-retinal (using the same ab
initio FF-optimized ligand structure as in Validation for
Function Prediction HierDock Protocol for 11-cis-retinal on
Bovine Rhodopsin). Again the molecule includes the
aldehyde group (no assumed formation of the Schiff base).
FIGURE 7 (A) Comparison of the
predicted structure (orange) Apo/
closed(MS) with the experimental
structure (blue) Apo/closed(xray). They
differ in the TM helical region by
CRMS ¼ 2.84 A˚. (B) Comparison of
the predicted Apo/closed(MS) structure
(orange) with the predicted Apo/
open(MS) structure (blue). They differ
in the TM helical region by 0.11 A˚.
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Apo/closed(MS)
Scanning the entire Apo/closed(MS) receptor to ﬁnd the
binding site and binding energy for 11-cis-retinal used the
steps described in Computational Methods. The best scoring
conformation for 11-cis-retinal and its associated binding site,
denoted asNoSB-Ret(HD)/closed(MS), are shown in Fig. 9C.
Here NoSB indicates the structure without the Schiff base
covalent bond between the aldehyde group of 11-cis-retinal
and Lys-296. This conformation (no covalent attachment)
differs from Ret(HD)/closed(xtal) by 3.2 A˚ CRMS. We
should emphasize that the Apo/closed(MS) structure was
constructed purely from ab initio predictions with Mem-
bStruk, with no input from the x-ray crystal structure. Thus
nowhere did we assume a lysine covalent bond with retinal in
any of the docking procedures. Yet, the predicted structure
identiﬁes which Lys can bond to the retinal, with 2.85 A˚
between the predicted position of the retinal oxygen and the
predicted position of the Lys-296 nitrogen.
Then starting with NoSB-Ret(HD)/closed(MS), we formed
this Schiff’s base bond (eliminating H2O), and optimized the
full ligand-protein complex with conjugate gradient minimi-
zation to obtain the Ret(HD)/closed(MS) structure. This
differs from Ret(HD)/closed(xtal) by 2.92 A˚ CRMS. These
structures are compared in Fig. 8, A and B.
A second criterion for validity of the predicted binding site
is to identify the residues interacting most strongly with the
ligand, which can be used to predict mutational studies for
validation and to design antagonists or agonists. Considering
the binding site to be all residues within 5.0 A˚ of the ligand
leads to 30 residues for Ret(xtal)/closed(xtal). For Ret(HD)/
closed(MS) we ﬁnd 26 residues (26 in common with Ret(x)/
closed(xtal)) and for Ret(HD)/closed(xtal) weﬁnd 23 residues
(15 in common with Ret(x)/closed(xtal)) in the binding site.
More important is to establish which of these residues is
responsible for ligand stabilization. Thus we calculated the
interactions of all amino acid residues within 5 A˚ of the ligand
and kept those that have a more favorable interaction than –1
kcal/mol interaction energy with the ligand. For Ret(xtal)/
closed(xtal) this leads to the 15 residues shown in Fig. 10 A.
For Ret(HD)/closed(MS) we ﬁnd 10 residues (8 in common
with Ret(x)/closed(xtal)) shown in Fig. 10B and for Ret(HD)/
closed(xtal) we ﬁnd 14 residues (12 of which in commonwith
Ret(x)/closed(xtal)) shown in Fig. 10 C. The interaction
energies of the residues are shown in Table S2. The side
chains identiﬁed as important include Trp-265 and Tyr-268,
which have been implicated (Lin and Sakmar, 1996) to
modulate the absorption frequency of 11-cis-retinal.
To provide an idea of how the retinal binds before Schiff
base bond formation, we also considered the binding site as
all residues within 5.0 A˚ of the ligand before bond formation
that have a more favorable interaction than –1 kcal/mol
interaction energy with the ligand. For NoSB-Ret(HD)/
closed(xtal) this leads to the seven residues shown in Fig. 9
B. For NoSB-Ret(HD)/closed(MS) we ﬁnd eight (six in
common with NoSB-Ret(HD)/closed(xtal)) shown in Fig. 9
C. The interaction energies of the residues are shown in
Table S1. Of the top interacting residues (three residues) in
NoSB-Ret(HD)/closed(xtal), two (Tyr-268 and Lys-296) are
also shown to rank among the top three in NoSB-Ret(HD)/
closed(MS). The residue which was missed (Thr-118)
ranked lower in NoSB-Ret(HD)/closed(MS) because it is
actually closer to the retinal (in comparison with the NoSB-
Ret(HD)/closed(xtal) structure), with distances as low as
2.8 A˚ (whereas an optimal van der Waals distance is;3.4 A˚)
to the polyene chain of retinal.
We conclude that the MembStruk-predicted structure is
useful for predicting binding sites sufﬁciently well to direct
mutation studies to elucidate the precise site.
Apo/open(MS)
We scanned the entire Apo/open(MS) receptor to ﬁnd the
binding site and binding energy for 11-cis-retinal using the
FIGURE 8 MembStruk validation using the closed EC-II loop. (A) The
HierDock-predicted conformation of 11-cis-retinal (colored by element) in
the MembStruk-predicted Apo/closed(MS) structure, denoted NoSB-
Ret(HD)/closed(MS). Note that the aldehyde oxygen is 2.85 A˚ from the N
of Lys-296. (B) The retinal structure after forming this Schiff base bond of
11-cis-retinal to Lys-296 and optimizing to form Ret(HD)/closed(MS)
(violet). Ret(HD)/closed(xtal) (blue). These ligand structures were found to
differ by 2.9 A˚ CRMS.
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steps described in Computational Methods. The best scoring
conformation for 11-cis-retinal and its associated binding site,
denoted as NoSB-Ret(HD)/open(MS), are shown in Fig. 9 D.
The predicted structure identiﬁes which Lys can bond to the
retinal, with 2.87 A˚ between the predicted position of the
retinal oxygen and the predicted position of the Lys-296
nitrogen.
Then starting with NoSB-Ret(HD)/open(MS), we formed
this Schiff base bond (eliminating H2O), and optimized the
full ligand-protein complex with conjugate gradient mini-
mization to obtain the Ret(HD)/open(MS) structure, This is
no experimental structure with which to compare, but this
structure differs from Ret(HD)/closed(MS) by 1.7 A˚ CRMS.
These structures are compared in Fig. 11, A and B.
A second criterion for validity of the predicted binding
site is in identifying those residues close to the ligand to
consider for mutational studies and drug design. Consider-
ing the binding site of NoSB-Ret(HD)/open(MS) as all
residues within 5.0 A˚ of the ligand, the amino acid residues
which interact with\1 kcal/mol interaction energy with
the ligand (10 residues) are shown in Fig. 9 D. Of these, six
residues are also shown to interact with the ligand in the
NoSB-Ret(HD)/closed(MS) structure discussed in the sub-
section called Apo/Closed(MS). We also ﬁnd four addi-
tional residues (Phe-276, Phe-208, Val-271, and Ala-272)
that do not bind with 1 kcal/mol in the NoSB-Ret(HD)/
closed(MS) structure. This difference results from the shift
in the retinal binding site upon opening of the EC-II loop.
FIGURE 9 (A–D) Comparison of predicted binding sites for retinal (those residues within 5 A˚ of retinal that interact strongly with the ligand (contributions
to binding[1 kcal/mol) before Schiff base bond formation in the three rhodopsin structures. (A) All three structures and ligand conformations are shown. The
colors blue, gray, and orange correspond respectively to those structures analyzed in B–D. (B) NoSB-Ret(HD)/closed(xtal) structure. Here we see that seven
residues bind more strongly than 1 kcal/mol. (C) NoSB-Ret(HD)/closed(MS). Here we see that ﬁve of the seven residues in B are predicted (only Phe-208 and
Hsp-211, both rather weakly bound). We also ﬁnd three additional residues (Phe-212, Ile-275, and Ala-117) that do not bind with 1 kcal/mol in B. (D) NoSB-
Ret(HD)/open(MS). Here we see that six of the seven residues in C bind more strongly than 1 kcal/mol. We also ﬁnd four additional residues that do not bind
with 1 kcal/mol in B. This difference results from the shift in the retinal binding site upon closure of the EC-II loop. The side chains in common with the NoSB-
Ret(HD)/closed(xtal) structure (in B) or with NoSB-Ret(HD)/closed(MS) (in C) within the binding site around the 11-cis-retinal are labeled with larger type.
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Thus, we consider that the retinal bound to the open-loop
structure is partially stabilized by van der Waals inter-
actions.
Exploring the signaling mechanism
Using MembStruk we predicted the two structures Apo/
open(MS) with the EC-II in an open conformation and Apo/
closed(MS) with it closed. The crystal structure of rhodopsin
has the closed conﬁguration in which EC-II has a well-
deﬁned b-sheet structure with the 11-cis-retinal bound. We
speculate that changes in the structure of this loop are
involved in activation of G-protein and in the entry of 11-cis-
retinal on the extracellular side of rhodopsin. The idea is
illustrated in Fig. 4, in which the helix 3 coupled to this loop
by a cysteine bond is the gatekeeper which responds to
signaling structural substates of rhodopsin as follows.
FIGURE 10 (A–C) Comparison of predicted binding sites of retinal with
Schiff base bond formed. We considered residues within a 5 A˚ shell of the
ligand (excluding the Lys-296 to which the retinal is bound) and determined
those that contribute at least 1 kcal/mol of stabilization energy for the three
rhodopsin structures. (A) Ret(xtal)/closed(xtal) structure. Here we see that 15
residues bind more strongly than 1 kcal/mol. (B) Ret(HD)/closed(xtal). Here
we see that 12 of the 15 residues in A are predicted to bind strongly (Ala-117
and His-211 still contribute positively to bonding but are now rather weakly
bound, at\1 kcal/mol). We ﬁnd two additional residues (Cys-187 and Ala-
269) that did not bind with 1 kcal/mol in A. (C) Ret(HD)/closed(MS). Here
we ﬁnd 8 of the 15 residues in A still bind strongly. We also ﬁnd two
additional residues (Ile-275 and Ala-269) that did not bind with 1 kcal/mol in
A. A larger type is used to label the side chains in common with the Ret(xtal)/
closed(xtal) structure within the binding site around the 11-cis-retinal.
FIGURE 11 MembStruk validation using the open EC-II loop. (A) The
HierDock-predicted conformation (colored by element) of 11-cis-retinal in
the MembStruk-predicted structure to form the NoSB-Ret(HD)/open(MS)
structure. Note that the aldehyde oxygen is 2.87 A˚ from the N of Lys-296,
which is short enough to form a hydrogen bond. (B) The Ret(HD)/open(MS)
structure after forming the Schiff base bond (green), compared with the
structure (violet) of 11-cis-retinal in Ret(HD)/closed(MS). These ligand
structures differ by 1.7 A˚ CRMS. The EC-II loop may function to position
the retinal ligand into its ﬁnal conformation as found in the rhodopsin crystal
structure.
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Starting with the inactive form Ret/closed with 11-cis-
retinal covalently linked to the rhodopsin, the response to
visible light causes the 11-cis-retinal to isomerize to all-
trans-retinal, which in turn causes changes in the conforma-
tion (Altenbach et al., 2001a,b, 1996; Farrens et al., 1996)
near the retinal that eventually leads to a structure in which
the all-trans-retinal is covalently linked to the open form
with a structure resembling the trans-Ret(HD)/open(MS)
structure from our calculations.
The transformation from closed to open in Step 1 is caused
by conformational changes responsible for activation (per-
haps by the direct interaction of the trans-isomer with helix 3,
to induce helix 3 to shift toward the extracellular side,
breaking the DRY-associated salt bridges at the intracellular
side).
Other processes hydrolyze off the trans-retinal to form
a structure similar to Apo/open(MS) and then other pro-
cesses reattach 11-cis-retinal to form a structure similar to
Ret(HD)/open(MS).
The Ret(HD)/open(MS) relaxes eventually to form
Ret(HD)/closed(MS), the inactive form. In this process the
EC-II loop closes, perhaps caused by the helix 3 shifting
toward the intracellular side, reforming the DRY-associated
salt bridges at that end with the ﬁnal result that the EC-II
closes to form a structure similar to the inactive form.
Thus by using MembStruk and HierDock we have
generated a total of six structures (summarized later) for
ligand/protein complexes that can now be used to explore all
the processes involving ligand binding and GPCR activation.
The experiment provided just one of these six structures, but
the validation with experiment allows us to have greater
conﬁdence in those ﬁve for which experimental structures
are not available.
COMPARISON TO OTHER METHODS
There have been attempts to model the structure of GPCRs
using homology modeling methods with either the bacterio-
rhodopsin or bovine rhodopsin crystal structure as template
(Strader et al., 1994). Since there is only one known
structure, these homology applications lead to transmem-
brane regions very similar to the bovine rhodopsin template
structure. Moreover, many important GPCR targets have
only low homology to bovine rhodopsin, making the models
particularly unreliable (Archer et al., 2003). Thus the se-
quence identity of bovine rhodopsin to dopamine D2 recep-
tor is 17%, to serotonin H1A 14%, and to G2A 13%, whereas
good structures from homology models generally require
[45% sequence identity.
GPCR structures have also been modeled using the
properties of conserved residues in multiple sequence
alignments followed by optimization of the structure using
distance restraint to maximize the hydrogen bonds (Lomize
et al., 1999). Distance restraints from various experiments
were also used to predict the structure of bacteriorhodopsin
(Herzyk and Hubbard, 1995). Comparing the TM helical
region of their predicted structure to a bundle of ideal helices
(i.e., not bent) superimposed on the bacteriorhodopsin
electron cryomicroscopy structure, they reported a CRMS
of 1.87 A˚ in the C-alphas.
Shacham et al. (2001) claim to have predicted the structure
of bovine rhodopsin using an approach based on speciﬁcity
of protein-protein interaction and protein-membrane inter-
action and the amphipathic nature of the helices. However,
they have not yet provided any details of their method or of
predictions on other GPCRs.
SUMMARY
Using MembStruk we predicted the three-dimensional
structure of bovine rhodopsin protein interacting with 11-
cis-retinal using only primary sequence information. This led
to the following structures.
Apo/closed(MS) is the MembStruk-predicted structure of
the closed form, without the retinal. The transmembrane
assembly for this structure deviates from Apo/closed(xtal) by
2.84 A˚ CRMS for the main-chain atoms (4.04 A˚ CRMS for
all transmembrane atoms, excluding H). Starting with the
crystal structure and minimizing using the DREIDING FF
leads to a structure that deviates from the crystal by 0.29 A˚
CRMS, indicating that the FF leads to a good description.
Thus most of the 2.8 A˚ CRMS error is due to the MembStruk
process.
Ret(HD)/closed(MS) is the predicted structure for 11-cis-
retinal obtained by applying HierDock to Apo/closed(MS).
This leads to close contact (2.8 A˚) between the carbonyl of
the retinal and the N of Lys-296. Forming the Schiff base
linkage and minimizing leads to the Ret(HD) structure that
deviates from Ret(HD)/closed(xtal) by 2.92 A˚ CRMS.
Carrying out the same HierDock process for the minimized
crystal structure leads to a predicted structure for 11-cis-
retinal that deviates from Ret(xtal) by 0.62 A˚ CRMS. This
indicates that it is, in fact, errors in the predicted protein
structure that are responsible for the errors in ligand
prediction.
Trans-Ret(HD)/closed(MS) is the predicted structure for
all-trans-retinal obtained by converting 11-cis-retinal to all-
trans and allowing the protein to respond. There is no ex-
perimental structure with which to compare.
Apo/open(MS) is the MembStruk-predicted structure of
the open form without the retinal. There are no experiments
withwhich to compare. This structure differs in the TM region
from Apo/closed(MS) by 0.11 A˚.
NoSB-Ret(HD)/open(MS) is the predicted structure for 11-
cis-retinal obtained by applying HierDock to Apo/open(MS).
There is no experimental structure with which to compare.
Ret(HD)/open(MS) is formed from NoSB-Ret(HD)/
open(MS) by forming the Schiff base linkage to Lys-296
andminimizing. There are no experimentswithwhich to com-
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pare. The retinal differs from that in Ret(HD)/closed(MS)
by 1.74 A˚.
The validation with experiment is sufﬁciently good that
we can now start to explore the mechanisms by carrying out
long timescale molecular dynamics and Monte Carlo cal-
culations on these various forms to learn more about the
mechanism of activation. Comparisons of the structures and
energetics for these systems provide information that might
be useful for understanding the mechanisms of binding and
activation in rhodopsin in particular and GPCRs in general.
We have noted above several steps for which we anticipate
substantial improvements and we are continuing to improve
the methods. For example the individual optimization of the
helices can be performed under a more constrained environ-
ment by performing torsional dynamics of each helix in the
presence of other helices or by performing torsional dynamics
of all helices simultaneously. For improved accuracy in
predicting the structures and for predicting the ligand binding
energy, we also intend to take into account the differential
solvent dielectric environment between membrane and the
hydrophilic and interfacial dielectric constants (Spassov et al.,
2002).
CONCLUSIONS
These applications of TM2ndS, MembStruk, and HierDock
to bovine rhodopsin validate these techniques for predicting
both the structure of membrane-bound proteins and the
binding site of ligands to these proteins. The predictions from
such studies can be used to design experiments to test details
of the structures that might lead to improved structures. This
could lead to structures more accurate than any of these
techniques individually. The HierDock and MembStruk
techniques validated here should also be useful for applica-
tions to other GPCRs, particularly for targeting agonists and
antagonists against speciﬁc subtypes.
In addition, these studies open the door to examination of
the mechanism for activation (structural and energy changes)
of signaling. Obtaining independent structures for each of the
major steps involved in binding and activation (e.g., the six
structures discussed for retinal-rhodopsin) provides the basis
for computational studies and for experiments that should
provide a basis for detailed examination of each step.
SUPPLEMENTAL MATERIAL
An online supplement to this article can be found by visiting
BJ Online at http://www.biophysj.org.
This research was supported partially by National Institutes of Health grants
BRGRO1-GM625523, R29AI40567, and HD365385. The computational
facilities were provided by a Shared University Research grant from IBM
and Defense University Research Instrumentation Program grants from the
Army Research Ofﬁce (ARO) and the Ofﬁce of Naval Research (ONR).
The facilities of the Materials and Process Simulation Center are also
supported by the Department of Energy, the National Science Foundation,
the Multidisciplinary University Research Initiative (MURI)-ARO, MURI-
ONR, General Motors, ChevronTexaco, Seiko-Epson, the Beckman Insti-
tute, and Asahi Kasei.
REFERENCES
Altenbach, C., K. Yang, D. L. Farrens, Z. T. Farahbakhsh, H. G. Khorana,
and W. L. Hubbell. 1996. Structural features and light-dependent
changes in the cytoplasmic interhelical E-F loop region of rhodopsin:
a site-directed spin-labeling study. Biochemistry. 35:12470–12478.
Altenbach, C., K. Cai, J. Klein-Seetharaman, H. G. Khorana, and W. L.
Hubbell. 2001a. Structure and function in rhodopsin: mapping light-
dependent changes in distance between residue 65 in helix TM1 and
residues in the sequence 306–319 at the cytoplasmic end of helix TM7
and in helix H8. Biochemistry. 40:15483–15492.
Altenbach, C., J. Klein-Seetharaman, K. Cai, H. G. Khorana, and W. L.
Hubbell. 2001b. Structure and function in rhodopsin: mapping light-
dependent changes in distance between residue 316 in helix 8 and
residues in the sequence 60–75, covering the cytoplasmic end of helices
TM1 and TM2 and their connection loop CL1. Biochemistry. 40:15493–
15500.
Altschul, S. F., T. L. Madden, A. A. Schaffer, J. Zhang, Z. Zhang, W.
Miller, and D. J. Lipman. 1997. Gapped BLAST and PSI-BLAST: a new
generation of protein database search programs. Nucleic Acids Res.
25:3389–3402.
Altschul, S. F., W. Gish, W. Miller, W. E. Myers, and D. J. Lipman. 1990.
Basic local alignment search tool. J. Mol. Biol. 215:403–410.
Archer, E., B. Maigret, C. Escrieut, L. Pradayrol, and D. Fourmy. 2003.
Rhodopsin crystal: new template yielding realistic models of G-protein-
coupled receptors? Trends Pharmacol. Sci. 24:36–40.
Borhan, B., M. L. Souto, H. Imai, Y. Schichida, and K. Nakanashi. 2000.
Movement of retinal along the visual transduction path. Science.
288:2209–2212.
Bourne, H. R., and E. C. Meng. 2000. Structure—rhodopsin sees the light.
Science. 289:733–734.
Bower, M., F. E. Cohen, and R. L. Dunbrack, Jr. 1997. Prediction of
protein side-chain rotamers from a backbone-dependent rotamer library:
a new homology modeling tool. J. Mol. Biol. 267:1268–1282.
Brameld, K. A., and W. A. Goddard. 1999. Ab initio quantum mechanical
study of the structures and energies for the pseudorotation of 59-
dehydroxy analogues of 29-deoxyribose and ribose sugars. J. Am. Chem.
Soc. 121:985–993.
Cornette, J. L., K. B. Cease, H. Margalit, J. L. Spouge, J. A. Berzofsky, and
C. Delisi. 1987. Hydrophobicity scales and computational techniques for
detecting amphipathic structures in proteins. J. Mol. Biol. 195:659–685.
Datta, D., N. Vaidehi, X. Xu, and W. A. Goddard 3rd. 2002. Mechanism
for antibody catalysis of the oxidation of water by singlet dioxygen.
Proc. Natl. Acad. Sci. USA. 99:2636–2641.
Datta, D., N. Vaidehi, W. B. Floriano, K. S. Kim, N. V. Prasadarao, and
W. A. Goddard. 2003. Interaction of E. coli outer-membrane protein A
with sugars on the receptors of the brain microvascular endothelial cells.
Proteins. 50:213–221.
Ding, H. Q., N. Karasawa, and W. A. Goddard. 1992. Atomic level
simulations on a million particles—the cell multipole method for
Coulomb and London nonbond interactions. Chem. Phys. Lett. 97:
4309–4315.
Donnelly, D. 1993. Modeling alpha-helical transmembrane domains.
Biochem. Soc.21:36–39.
Donnelly, D., J. P. Overington, and T. L. Blundell. 1994. The prediction
and orientation of alpha-helices from sequence alignments—the
combined use of environment-dependent substitution tables, Fourier-
transform methods and helix capping rules. Protein Eng. 7:645–653.
Eisenberg, D., R. M. Weiss, and T. C. Terwilliger. 1984. The hydrophobic
moment detects periodicity in protein hydrophobicity. Proc. Natl. Acad.
Sci. USA. 8:140–144.
1920 Trabanino et al.
Biophysical Journal 86(4) 1904–1921
Eisenberg, D., R. M. Weiss, T. C. Terwilliger, and W. Wilcox. 1982.
Hydrophobic moments and protein structure. Faraday Symp. Chem. Soc.
17:109–120.
Ewing, T. A., and I. D. Kuntz. 1997. Critical evaluation of search
algorithms for automated molecular docking and database screening.
J. Comput. Chem. 18:1175–1189.
Farrens, D. L., C. Altenbach, K. Yang, W. L. Hubbell, and H. G. Khorana.
1996. Requirement of rigid-body motion of transmembrane helices for
light activation of rhodopsin. Science. 274:768–770.
Floriano, W. B., N. Vaidehi, M. Singer, G. Shepherd, and W. A. Goddard
3rd. 2000. Molecular mechanisms underlying differential odor responses
of a mouse olfactory receptor. Proc. Natl. Acad. Sci. USA. 97:10712–
10716.
Floriano, W. B., N. Vaidehi, and W. A. Goddard 3rd. 2004a. Making sense
of olfaction through molecular structure and function prediction of
olfactory receptors. Chem. Senses. In press.
Floriano, W. B., N. Vaidehi, G. Zamanakos, and W. A. Goddard 3rd.
2004b. Virtual ligand screening of large molecule databases using
hierarchical docking protocol (HierVLS). J. Med. Chem. 47:56–71.
Freddolino, P. L., M. Yashar, S. Kalani, N. Vaidehi, W. B. Floriano, S. E.
Hall, R. J. Trabanino, V. W. T. Kam, and W. A. Goddard 3rd. 2004.
Predicted 3D structure for the human b2 adrenergic receptor and its
binding site for agonists and antagonists. PNAS. 101:2736–2741.
Greasley, P. J., F. Fanelli, O. Rossier, L. Abuin, and S. Cotecchia. 2002.
Mutagenesis and modelling of the a1b-adrenergic receptor highlight the
role of the helix 3/helix 6 interface in receptor activation. Mol. Pharma.
61:1025–1032.
Herzyk, P., and R. E. Hubbard. 1995. Automated method for modeling
seven-helix transmembrane receptors from experimental data. Biophys. J.
69:2419–2442.
Jain, A., N. Vaidehi, and G. Rodriguez. 1993. A fast recursive algorithm for
molecular-dynamics simulation. J. Comput. Phys. 106:258–268.
Kalani, M. Y. S., N. Vaidehi, S. E. Hall, R. J. Trabanino, P. L. Freddolino,
M. A. Kalani, W. B. Floriano, V. W. T. Kam, and W. A. Goddard 3rd.
2004. The predicted 3D structure of the human D2 dopamine receptor
and the binding site and binding afﬁnities for agonists and antagonists.
PNAS. 103:3815–3820.
Kekenes-Huskey, P. M., N. Vaidehi, W. B. Floriano, and W. A. Goddard.
2003. Fidelity of phenyl alanyl tRNA synthetase in binding the natural
amino acids. J. Chem. Phys. 107:11549–11557.
Laskowski, R. A., M. W. MacArthur, D. S. Moss, and J. M. Thornton.
1993. PROCHECK—a program to check the stereochemical quality of
protein structures. J. Appl. Crystallogr. 26:283–291.
Lim, K.-T., S. Brunett, M. Iotov, R. B. McClurg, N. Vaidehi, S. Dasgupta,
S. Taylor, and W. A. Goddard 3rd. 1997. Molecular dynamics for very
large systems on massively parallel computers: the MPSim program.
J. Comput. Chem. 18:501–521.
Lin, S. W., and T. P. Sakmar. 1996. Speciﬁc tryptophan UV-absorbance
changes are probes of the transition of rhodopsin to its active state.
Biochemistry. 35:11149–11159.
Lomize, A. L., I. D. Poghozeva, and H. I. Mosberg. 1999. Structural
organization of G-protein-coupled receptors. J. Comp. Aided Mol.
Design. 13:325–353.
MacKerell, A. D., D. Bashford, M. Bellott, R. L. Dunbrack, J. D. Evanseck,
M. J. Field, S. Fischer, J. Gao, H. Guo, S. Ha, D. Joseph-McCarthy,
I. Kuchnir, K. Kuczera, F. T. K. Lau, C. Mattos, S. Michnick, T. Ngo,
D. T. Nguyen, B. Prodhom, W. E. Reiher, B. Roux, M. Schlenkrich,
J. C. Smith, R. Stote, J. Straub, M. Watanabe, J. Wiorkiewicz-Kuczera,
D. Yin, and M. Karplus. 1998. All-atom empirical potential for mole-
cular modeling and dynamics studies of proteins. J. Phys. Chem. B. 102:
3586–3616.
Malnic, B., J. Hirono, T. Sato, and L. B. Buck. 1999. Combinatorial
receptor codes for odors. Cell. 96:713–723.
Marti-Renom, M. A., A. C. Stuart, A. Fiser, R. Sanchez, F. Melo, and
A. Sali. 2000. Comparative protein structure modeling of genes and
genomes. Annu. Rev. Biophys. Biomem. 29:291–325.
Mathiowetz, A. M., A. Jain, N. Karasawa, and W. A. Goddard 3rd. 1994.
Protein simulations using techniques suitable for very large systems—the
cell multipole method for nonbond interactions and the Newton-Euler
inverse mass operator method for internal coordinate dynamics. Proteins.
20:227–247.
Mayo, S. L., B. D. Olafson, and W. A. Goddard 3rd. 1990. DREIDING—
a generic force ﬁeld for molecular simulations. J. Phys. Chem. 94:8897–
8909.
Melia, T. J., C. W. Cowan, J. K. Angleson, and T. G. Wensel. 1997. A
comparison of the efﬁciency of G-protein activation by ligand-free and
light-activated forms of rhodopsin. Biophys. J. 73:3182–3191.
Okada, T., O. P. Ernst, K. Palczewski, and K. P. Hofmann. 2001.
Activation of rhodopsin: new insights from structural and biochemical
studies. Trends Biochem. Sci. 26:318–324.
Palczewski, K., T. Kumasaka, T. Hori, C. Behnke, H. Motoshima, B. Fox,
I. Trong, D. Teller, T. Okada, R. Stenkamp, M. Yamamoto, and M.
Miyano. 2000. Crystal structure of rhodopsin: a G-protein-coupled
receptor. Science. 289:739–745.
Rappe´, A. K., and W. A. Goddard 3rd. 1991. Charge equilibration for
molecular-dynamics simulations. J. Phys. Chem. 95:3358–3363.
Saam, J., E. Tajkhorshid, S. Hayashi, and K. Schulten. 2002. Molecular
dynamics investigation of primary photoinduced events in the activation
of rhodopsin. Biophys. J. 83:3097–3112.
Schertler, G. F. X. 1998. Structure of rhodopsin. Eye. 12:504–510.
Scho¨neberg, T., A. Schulz, and T. Gudermann. 2002. The structural basis of
G-protein-coupled receptor function and dysfunction in human diseases.
Rev. Phys. Biochem. Pharm. 144:145–227.
Shacham, S., M. Topf, N. Avisar, F. Glaser, Y. Marantz, S. Bar-Haim,
S. Noiman, Z. Naor, and O. M. Becker. 2001. Modeling the three-
dimensional structure of GPCRs from sequence. Med. Res. Rev. 21:
472–483.
Spassov, V. Z., L. Yan, and S. Szalma. 2002. Introducing an implicit
membrane in Generalized-Born solvent accessibility continuum solvent
models. J. Phys. Chem. B. 106:8726–8738.
Strader, C. D., T. M. Fong, M. R. Tota, D. Underwood, and R. A. Dixon.
1994. Structure and function of G-protein-coupled receptors. Annu. Rev.
Biochem. 63:101–132.
Strange, P. G. 1998. Three-state and two-state models. Trends Pharm. Sci.
19:85–86.
Thompson, J. D., D. G. Higgins, and T. J. Gibson. 1994. Clustal-
W—improving the sensitivity of progressive multiple sequence align-
ment through sequence weighting, position-speciﬁc gap penalties and
weight matrix choice. Nucleic Acids Res. 22:4673–4680.
Vaidehi, N., W. B. Floriano, R. Trabanino, S. E. Hall, P. Freddolino, E. J.
Choi, G. Zamanakos, and W. A. Goddard. 2002. Prediction of structure
and function of G-protein-coupled receptors. Proc. Natl. Acad. Sci. USA.
99:12622–12627.
Vaidehi, N., A. Jain, and W. A. Goddard 3rd. 1996. Constant temperature
constrained molecular dynamics: the Newton-Euler inverse mass
operator method. J. Phys. Chem. 100:10508–10517.
Vriend, G. 1990. WHAT IF—a molecular modeling and drug design
program. J. Mol. Graph. 8:52–56.
Wallin, E., and G. von Heijne. 1998. Genome-wide analysis of integral
membrane proteins from eubacterial, archaean, and eukaryotic organ-
isms. Protein Sci. 7:1029–1038.
Wang, P., N. Vaidehi, D. A. Tirrell, and W. A. Goddard 3rd. 2002. Virtual
screening for binding of phenylalanine analogues to phenylalanyl-tRNA
synthetase. J. Am. Chem. Soc. 124:14442–14449.
Wilson, S., and D. Bergsma. 2000. Orphan G-protein-coupled receptors:
novel drug targets for the pharmaceutical industry. Drug Des. Discov.
17:105–114.
Zamanakos, G. 2002. A fast and accurate analytical method for the
computation of solvent effects in molecular simulations. Chemistry PhD
thesis. California Institute of Technology, Pasadena, CA.
GPCR Structure Prediction 1921
Biophysical Journal 86(4) 1904–1921
